Skin Cancer - Scientists Double Understanding Of Genetic Risk Of Melanoma
Can't see this email? View it online
   
  Skin Cancer  
  The latest skin cancer news from News Medical  
 Keratinocyte Stem Cells: An OverviewKeratinocyte Stem Cells: An Overview
 
The skin provides an essential first line of defense protecting the body against potentially threatening substances in the environment.
 
   Scientists Double Understanding Of Genetic Risk Of MelanomaScientists Double Understanding Of Genetic Risk Of Melanoma
 
A global collaboration of scientists has more than doubled the known number of regions on the human genome that influence the risk of developing melanoma.
 
   Interleukin-12 electroporation led to clinical responses in patients with advanced melanomaInterleukin-12 electroporation led to clinical responses in patients with advanced melanoma
 
Combining intratumoral electroporation of interleukin-12 (IL-12) DNA (tavokinogene telseplasmid, or TAVO) with the immune checkpoint inhibitor pembrolizumab (Keytruda) led to clinical responses in patients with immunologically quiescent advanced melanoma, according to results from a phase II trial.
 
 UC researchers uncover potential new treatment for patients with metastatic melanoma
 
UC researchers uncover potential new treatment for patients with metastatic melanomaResearchers at the University of Cincinnati have uncovered a potentially more beneficial treatment regimen for patients with metastatic melanoma.
 
 
 Inherited genetic variations can alter progression of melanoma, indicates study
 
Inherited genetic variations can alter progression of melanoma, indicates studySometimes cancer stays put, but often it metastasizes, spreading to new locations in the body. It has long been suspected that genetic mutations arising inside tumor cells drive this potentially devastating turn of events.
 
 
 Study finds racial differences in time from diagnosis to definitive surgery for melanoma
 
Study finds racial differences in time from diagnosis to definitive surgery for melanomaBlack patients with one of the deadliest forms of skin cancer are likely to experience a longer delay from diagnosis to surgery than non-Hispanic white patients, according to a new study published in the Journal of the American Academy of Dermatology.